Earnings Call · Q4 FY2024·2025-02-06

Q4 24EPS -12.44%·Rev n/aQ3 24EPS -0.55%·Rev n/aQ2 24EPS +6.54%·Rev n/aQ1 24EPS -6.98%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Investor Relations

Kyle Gano — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eric Benevich — Chief Commercial Officer

Eiry Roberts — Chief Scientific Officer

−18.5%1d on move date−17.6% vs SPY3d−22.4%5d−22.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access